NCT06981624 Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion
| NCT ID | NCT06981624 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Olivier F. Bertrand |
| Condition | Radial Artery Occlusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-05-13 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2025-05-13 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.
Eligibility Criteria
Inclusion Criteria: * Any patient referred for a diagnostic transradial catheterism Exclusion Criteria: * Unable to understand study design or provide informed consent * Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine * Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access. * Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06981624 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Radial Artery Occlusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06981624 currently recruiting?
Yes, NCT06981624 is actively recruiting participants. Contact the research team at michele.jadin@criucpq.ulaval.ca for enrollment information.
Where is the NCT06981624 trial being conducted?
This trial is being conducted at Québec, Canada.
Who is sponsoring the NCT06981624 clinical trial?
NCT06981624 is sponsored by Olivier F. Bertrand. The trial plans to enroll 500 participants.